Rao Sudha
Transaction: 06/19/2026
BUY
Change
+250,000
Price
$18.48
Filing
06/23/2026
Type
BUY
Kazia Therapeutics Ltd ADR
KZIA • Biotechnology
$12.31
▲ +0.15 (+1.23%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$38.41M
Growth
-33.7%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.35Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 16, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$12.31
Change1.23%
Shares Out3.12M
Market Cap$38.41M
52W Range4.86 - 17.40
Beta1.62
P/E-0.55
P/S0.00
P/B0.58
P/FCF-2.97
EV/Sales0.00
EV/EBITDA2.79
Price$12.31
Change1.23%
Shares Out3.12M
Market Cap$38.41M
52W Range4.86 - 17.40
Beta1.62
P/E-0.55
P/S0.00
P/B0.58
P/FCF-2.97
EV/Sales0.00
EV/EBITDA2.79
EV/FCF4.09
Earnings Yield-45.65%
FCF Yield-33.62%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-338.50%
Profit Margin-492.90%
Debt/Eq-0.05
Current Ratio0.35
Quick Ratio0.35
Revenue 5Y-33.73%
Target$31.50
Target Upside155.89%
Target Median$30.50
Target Range25.00 - 40.00
Volume167.98K
Avg Volume226.53K
EPS Surprise-0.57
Investment DNA
How strong this company looks for long-term investors
22
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Weak liquidity · 0.35Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Price Target
2026-06-24
Low
$25.00
Mean
$28.50
Median
$28.50
High
$32.00
Insider Transactions
Recent executive and insider activity
Levine James E.
Transaction: 06/19/2026
BUY
Change
+200,000
Price
$13.86
Filing
06/23/2026
Type
BUY
Levine James E.
Transaction: 06/01/2026
OTHER
Change
0
Price
Not reported
Filing
06/15/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rao Sudha | BUY | +250,000 | $18.48 | 06/19/2026 | 06/23/2026 |
| Levine James E. | BUY | +200,000 | $13.86 | 06/19/2026 | 06/23/2026 |
| Levine James E. | OTHER | 0 | Not reported | 06/01/2026 | 06/15/2026 |
| Davidson Ebru | OTHER | +75,000 | $8.00 | 03/18/2026 | 06/03/2026 |
| Rao Sudha | OTHER | 0 | Not reported | 04/13/2026 | 05/19/2026 |
| Friend John E. II | OTHER | +30,000 | $18.85 | 03/18/2026 | 04/09/2026 |
| Cain David | OTHER | +400,000 | $0.11 | 03/18/2026 | 04/01/2026 |
| Cain David | OTHER | +100,000 | $8.00 | 03/18/2026 | 04/01/2026 |
| APPLE ROBERT F | OTHER | +75,000 | $6.58 | 03/18/2026 | 03/18/2026 |
| Bonacorda Jeffrey | OTHER | +100,000 | $6.58 | 03/18/2026 | 03/18/2026 |
| Simpson Jeremy | OTHER | +100,000 | $0.67 | 03/18/2026 | 03/18/2026 |
| Friend John E. II | OTHER | +1,000,000 | $0.11 | 03/18/2026 | 03/18/2026 |
| Friend John E. II | OTHER | +500,000 | $6.58 | 03/18/2026 | 03/18/2026 |
| Coffey Steven R. S. | OTHER | +1,122 | Not reported | 03/18/2026 | 03/18/2026 |
| Coffey Steven R. S. | OTHER | +75,000 | $8.00 | 03/18/2026 | 03/18/2026 |
| Coffey Steven R. S. | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| AUSTIN JOSIAH T | SELL | -23,922 | $6.01 | 11/05/2013 | 11/06/2013 |
| AUSTIN JOSIAH T | SELL | -25,400 | $6.02 | 11/04/2013 | 11/06/2013 |
| AUSTIN JOSIAH T | SELL | -1,100 | $6.04 | 10/29/2013 | 10/29/2013 |
| AUSTIN JOSIAH T | SELL | -37,409 | $6.18 | 10/28/2013 | 10/29/2013 |